earn	recommendation reiterated wang labs wanb analyst thomas mccrann merrill lynch reiterated buy recommendation wang laboratories inc noting that successful cost cutting campaign reduce earnings loss expected for quarter ending march wang actively traded stock american stock exchange rising mccrann that wang bit ahead expected cost reductions and result odds increased that loss for quarter will had expected mccrann expects wang report break even earnings per share small loss per share for quarter for year company report loss cts share compared earnings cts share year ago InformationRetrieval.reuter